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Introduction {#sec005}
============

Obstructive sleep apnea (OSA) is a prevalent sleep breathing disorder affecting 9--25% of the general adult population.\[[@pone.0143697.ref001]\] It is associated with cardiovascular diseases, cerebrovascular diseases, metabolic disorders and impaired neurocognitive function.\[[@pone.0143697.ref002]--[@pone.0143697.ref004]\] It has been estimated that up to 80% of individuals with moderate-to-severe OSA may remain undiagnosed.\[[@pone.0143697.ref005]\] The prevalence is higher in the surgical population,\[[@pone.0143697.ref006],[@pone.0143697.ref007]\] with a prevalence rates as high as 70% in bariatric surgical patients.\[[@pone.0143697.ref008],[@pone.0143697.ref009]\] The majority of surgical patients with OSA remain undiagnosed and subsequently, are untreated at the time of presentation for surgery.\[[@pone.0143697.ref007]\] Given the important adverse consequences associated with untreated OSA, prompt diagnosis and treatment of unrecognized OSA is critical. The gold standard for diagnosis of OSA is an overnight polysomnogram (PSG). However, PSG is time consuming, labor intensive, and costly. Moreover, PSG requires the expertise of sleep medicine specialists, which may not be readily available at many hospitals and medical centers. Therefore, a simple and reliable method of identifying patients who are at high-risk of OSA and triaging them for prompt diagnosis and treatment is clinically relevant. A number of screening tests have been developed to identify high-risk patients.\[[@pone.0143697.ref010]--[@pone.0143697.ref016]\] However, many of these screening tests are lengthy and complicated, or require an upper airway assessment, making them inconvenient to use and may increase variability amongst clinicians performing the upper airway assessment.

The STOP-Bang questionnaire was first developed in 2008.\[[@pone.0143697.ref017]\] It is a simple, easy to remember, and self-reportable screening tool, which includes four subjective (STOP: **S**noring, **T**iredness, **O**bserved apnea and high blood **P**ressure) and four demographics items (Bang: **B**MI, **a**ge, **n**eck circumference, **g**ender).\[[@pone.0143697.ref017]\] The STOP-Bang questionnaire was originally validated to screen for OSA in the surgical population. The sensitivity for the STOP-Bang score ≥3 as the cut-off to predict any OSA (apnea hypopnea index (AHI) \>5), moderate-to-severe OSA (AHI \>15) and severe OSA (AHI \>30) was 83.9%, 92.9% and 100% respectively.\[[@pone.0143697.ref017]\] Due to its ease of use and high sensitivity, the STOP-Bang questionnaire has been widely used in preoperative clinics\[[@pone.0143697.ref017]--[@pone.0143697.ref019]\], sleep clinics\[[@pone.0143697.ref020]--[@pone.0143697.ref030]\], the general population\[[@pone.0143697.ref031]\] and other special populations\[[@pone.0143697.ref032],[@pone.0143697.ref033]\] to detect patients at high-risk of OSA. The purpose of this systematic review and meta-analysis is to determine the accuracy of the STOP-Bang questionnaire in screening patients for OSA and to evaluate the relationship between the STOP-Bang score and the probability of OSA among different patient populations.

Methods {#sec006}
=======

Literature search strategy and study selection {#sec007}
----------------------------------------------

We identified and reviewed published articles in which the STOP-Bang questionnaire was assessed as a screening tool for OSA among different patient populations. The literature search was performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analysis) guidelines and the search strategy was implemented with the help of an expert librarian familiar with the literature search.

### Electronic searches {#sec008}

All queries started in 2008 when the STOP-Bang was first published.\[[@pone.0143697.ref017]\] With the goal of completeness, a systematic search of the literature was carried out using multiple sources, including MEDLINE (from 2008 to January 2015), Medline-in-process & other non-indexed citations (up to January 2015), Embase (from 2008 to January 2015), Cochrane Central Register of Controlled Trials (up to January 2015), Cochrane Databases of Systematic Reviews (from 2008 to January 2015), Google Scholar, Web of Sciences (from 2008 to January 2015), Scopus (from 2008 to January 2015) and PubMed (from 2008 to January 2015) using the search strategy that was designed for each database. The search strategy included the following free-text and index terms: 'obstructive sleep apnea', 'obstructive sleep apnea syndrome', 'obstructive sleep apnoea', 'obstructive sleep apnoea syndrome', 'sleep disordered breathing', 'obesity hypoventilation syndrome', 'apnea or apnoea', 'hypopnea or hypopnoea', 'STOP-Bang', 'STOP Questionnaire'.

### Searching other resources {#sec009}

A citation search was also conducted by performing a manual review of references from the final articles analyzed as well as the related review articles.

### Selection of studies {#sec010}

Two reviewers (M.N., F.C.) independently screened the titles and abstracts of the search results. After excluding the irrelevant articles, full-text articles of the remaining publications were retrieved and carefully evaluated to determine if they met the following inclusion criteria: 1) The study evaluated the STOP-Bang questionnaire as a screening tool for OSA in adult subjects \>18 years; 2) The results of a PSG (either laboratory or portable) confirming the diagnosis of OSA; 3) OSA and its severity was defined by an AHI or a respiratory disturbance index (RDI); and 4) The full-text papers were written in the English language.

Data extraction and management {#sec011}
------------------------------

The two independent reviewers (M.N. & F.C.) extracted the data with a standard data collection form. For each study, a 2X2 contingency table was constructed using the predictive parameters for each AHI or RDI cut-off. Studies were excluded if there was inadequate information to create the 2x2 contingency tables or if there was an inadequate description of the methodology. The duplicates were removed and any disagreements were resolved by consulting with another author (P.L.). Unless specifically defined, the standard cut-off of the STOP-Bang questionnaire (STOP-Bang ≥3) was adopted. An AHI ≥5 or RDI ≥5 were considered as the diagnostic cut-off for OSA. An AHI ≥15 or RDI ≥15 were considered as the diagnostic cut-off for moderate-to-severe OSA, and AHI ≥30 or RDI ≥30 for severe OSA.

The following information was collected from each study: author, year of publication, type of study, type of patients (surgical patients, sleep clinic patients, general population, renal failure patients and highway bus drivers), sample size, validation process and tool, OSA definition and number of patients in each of the following categories: mild (AHI ≥5), moderate-to-severe (AHI ≥15 or RDI ≥15) and severe OSA (AHI ≥30 or RDI ≥30). The following clinic data were also extracted: age, gender, Body Mass Index (BMI), neck circumference, the STOP-Bang score, mean AHI/RDI and minimum SpO~2~.

Assessment of methodological quality {#sec012}
------------------------------------

The methodological quality of each study was assessed and any disagreements were resolved by consulting another author (PL). The validity criteria assessing the internal and external validity were explicitly described and coded according to the Cochrane Methods group on the screening and diagnostic tests.\[[@pone.0143697.ref034]\] The internal validity included the following factors: study design, definition of the disease, blind execution of the index test (STOP-Bang questionnaire) and the reference test (PSG), valid reference test, avoidance of verification bias, and independent interpretation of the test results. The external validity consisted of the following items: disease spectrum, clinical setting, demographic information, previous screening or referral filter, explicit cutoffs, percentage of missing patients, missing data management, and subject selection for PSG.

Statistical analysis {#sec013}
--------------------

The continuous data are presented as mean and standard deviation and categorical data as frequency and percentage. Using 2X2 contingency tables, we recalculated the following predictive parameters in each study: prevalence, sensitivity and specificity, positive predictive value (PPV) and negative predictive value (NPV), and diagnostic odds ratio (DOR). The area under the receiver operating characteristic (ROC) curve were calculated by logistic regression. The pooled predictive parameters (sensitivity and specificity, positive and negative predictive value, DOR and area under the ROC curve were obtained to assess the performance of each STOP-Bang score for the different AHI cut-offs (AHI ≥5, AHI ≥15 and AHI ≥30). The probability of moderate and severe OSA at the various STOP-Bang scores were pooled and presented as a bar graph.

The meta-analysis was carried out with Review Manager Version 5.3. Copenhagen (The Nordic Cochrane Centre, The Cochrane Collaboration, 2014) and Meta-Disc version 1.4 (Hospital Ramony Cajal, Madrid, Spain). The parameters were assessed separately for each population with similar characteristics (i.e. sleep clinic population, surgical population). The parameters from pooled data of each population were calculated and forest plots were created for the predictive parameters using a random effect model. DOR and ROC curve analysis was presented to assess the diagnostic ability of STOP-Bang questionnaire. Inconsistency was assessed using the Cochrane Q test (P value \<0.05: heterogeneity present) and I^2^ test (I^2^ \>33%: heterogeneity present).

Results {#sec014}
=======

Our initial search yielded 342 citations ([Fig 1](#pone.0143697.g001){ref-type="fig"}). After screening titles and abstracts, 309 studies were excluded due to not meeting the predetermined eligibility criteria. Of the remaining 33 studies, 16 studies were excluded and the reasons are listed in [S1 Appendix](#pone.0143697.s001){ref-type="supplementary-material"}.\[[@pone.0143697.ref035]--[@pone.0143697.ref050]\] Finally, seventeen studies were included in the review.\[[@pone.0143697.ref017]--[@pone.0143697.ref033]\] The included studies encompassed 9,206 patients and were conducted in nine different countries: Canada\[[@pone.0143697.ref017],[@pone.0143697.ref018],[@pone.0143697.ref025],[@pone.0143697.ref033]\], USA\[[@pone.0143697.ref021],[@pone.0143697.ref024],[@pone.0143697.ref026],[@pone.0143697.ref031]\], China\[[@pone.0143697.ref023],[@pone.0143697.ref028],[@pone.0143697.ref029]\] Brazil\[[@pone.0143697.ref019]\], Egypt\[[@pone.0143697.ref022]\], Singapore\[[@pone.0143697.ref020]\], Turkey\[[@pone.0143697.ref032]\], Portugal\[[@pone.0143697.ref030]\] and United Kingdom\[[@pone.0143697.ref027]\].

![Flow chart of screened, excluded and analyzed studies.](pone.0143697.g001){#pone.0143697.g001}

These 17 studies were included for systematic review. Out of which 11 studies in Sleep clinic population and 3 studies in surgical population are included for meta-analysis. Among the sleep clinic population, 11 studies (n = 3176)\[[@pone.0143697.ref020]--[@pone.0143697.ref030]\] were included for meta-analysis at the AHI cut-offs of ≥5 and ≥15, and 9 studies (n = 2996)\[[@pone.0143697.ref020]--[@pone.0143697.ref025],[@pone.0143697.ref028]--[@pone.0143697.ref030]\] for AHI ≥30. Among the surgical population, two studies (n = 923)\[[@pone.0143697.ref017],[@pone.0143697.ref018]\] were included for AHI ≥5, three (n = 1004)\[[@pone.0143697.ref017]--[@pone.0143697.ref019]\] for AHI ≥15, and two (n = 923)\[[@pone.0143697.ref017],[@pone.0143697.ref018]\] for AHI ≥30 ([Fig 2](#pone.0143697.g002){ref-type="fig"}). The information regarding the number of patients and the AHI validation among the general population\[[@pone.0143697.ref031]\], highway bus drivers\[[@pone.0143697.ref032]\] and renal failure patients\[[@pone.0143697.ref033]\] are also listed in [Fig 2](#pone.0143697.g002){ref-type="fig"}. For the meta-analysis, pooling of the data was performed within populations with similar characteristics (i.e. sleep clinic population and surgical population).

![Flow chart for data collection and grouping of the studies for systematic review and meta-analysis.\
AHI: Apnea-Hypopnea Index; RDI: Respiratory Disturbance Index; n: number of participants.](pone.0143697.g002){#pone.0143697.g002}

The validation characteristics and demographic data (expressed as mean±SD) of the included studies are summarized in Tables [1](#pone.0143697.t001){ref-type="table"} and [2](#pone.0143697.t002){ref-type="table"} respectively. The majority were prospective studies, in which patients completed the STOP-Bang questionnaire before undergoing PSG with only two being retrospective studies\[[@pone.0143697.ref021],[@pone.0143697.ref031]\]. There were variations in the cut-off criteria for defining OSA with fourteen studies using AHI ≥5 \[[@pone.0143697.ref017],[@pone.0143697.ref018],[@pone.0143697.ref020]--[@pone.0143697.ref030]\]. Two studies each defined OSA as either AHI ≥15\[[@pone.0143697.ref019],[@pone.0143697.ref032]\], or RDI ≥15 respectively.\[[@pone.0143697.ref031],[@pone.0143697.ref033]\].

10.1371/journal.pone.0143697.t001

###### The characteristics of the included studies.

![](pone.0143697.t001){#pone.0143697.t001g}

  Study                                              Type (n)                      Validation process & Tool              Prevalence   OSA definition   No OSA AHI \<5 (n)   Mild OSA AHI ≥5 (n)   Moderate-to-severe OSA AHI ≥15 or RDI \>15 (n)   Severe OSA AHI ≥30 or RDI ≥30 (n)
  -------------------------------------------------- ----------------------------- -------------------------------------- ------------ ---------------- -------------------- --------------------- ------------------------------------------------ -----------------------------------
  **Sleep clinic population**                                                                                                                                                                                                                       
    ^\[^ [@pone.0143697.ref020] ^\]^Ong ^2010^       Asian population (319)        Prospective Lab PSG                    77.7         AHI \>5          79                   240                   166                                              113
    ^\[^ [@pone.0143697.ref021] ^\]^Farney^2011^     American population (1426)    Retrospective Lab PSG                  89.5         AHI ≥5           150                  1274                  959                                              580
    ^\[^ [@pone.0143697.ref022] ^\]^El-Sayed^2012^   Egyptian population (234)     Prospective Lab PSG                    87.2         AHI ≥5           30                   204                   177                                              148
    ^\[^ [@pone.0143697.ref023] ^\]^Yu^2012^         Chinese population (114)      Prospective Lab PSG                    79.8         AHI ≥5           23                   91                    67                                               46
    ^\[^ [@pone.0143697.ref024] ^\]^Boynton^2013^    American population (219)     Prospective Lab PSG                    77.1         AHI \>5          50                   169                   103                                              62
    ^\[^ [@pone.0143697.ref025] ^\]^Pereire^2013^    Canadian population (128)     Prospective Lab PSG                    91.3         AHI \>5          12                   116                   88                                               56
    ^\[^ [@pone.0143697.ref026] ^\]^Vana^2013^       American population (47)      Prospective Lab PSG                    68.0         AHI \>5          15                   32                    19                                               9
    ^\[^ [@pone.0143697.ref027] ^\]^Cowan^2014^      British population (129)      Prospective Portable level 3 PSG       75.2         AHI ≥5           32                   97                    56                                               NA
    ^\[^ [@pone.0143697.ref028] ^\]^Ha^2014^         Chinese population (139)      Prospective Lab PSG                    79.8         AHI \>5          28                   111                   84                                               51
    ^\[^ [@pone.0143697.ref029] ^\]^Luo^2014^        Chinese population (194)      Prospective Lab PSG                    92.4         AHI ≥5           8                    186                   170                                              128
    ^\[^ [@pone.0143697.ref030] ^\]^Reis^2015^       Portuguese population (216)   Prospective Lab/portable level 3 PSG   78.1         AHI \>5          47                   168                   113                                              61
  **Surgical population**                                                                                                                                                                                                                           
    ^\[^ [@pone.0143697.ref017] ^\]^Chung^2008^      Canadian population (177)     Prospective Lab PSG                    68.9         AHI \>5          55                   122                   70                                               39
    ^\[^ [@pone.0143697.ref018] ^\]^Chung^2012^      Canadian population (746)     Prospective Lab/portable level 2 PSG   68.4         AHI \>5          236                  510                   287                                              134
    ^\[^ [@pone.0143697.ref019] ^\]^Nunes^2014^      Brazilian population (81)     Prospective Lab PSG                    48.1         AHI ≥15                               AHI \<15 = 43         38                                               NA
  **General population**                                                                                                                                                                                                                            
    ^\[^ [@pone.0143697.ref031] ^\]^Silva^2011^      American population (4770)    Retrospective Portable level 2 PSG     12.7         RDI ≥15                               RDI\<15 = 3822        948                                              345
  **Highway bus drivers**                                                                                                                                                                                                                           
    ^\[^ [@pone.0143697.ref032] ^\]^Firat^2012^      Turkish population (85)       Prospective Lab PSG                    54.1         AHI \>15                              AHI\<15 = 39          46                                               NA
  **Renal failure patients**                                                                                                                                                                                                                        
    ^\[^ [@pone.0143697.ref033] ^\]^Nicholl^2013^    Canadian population (172)     Prospective Portable level 3 PSG       42.4         RDI ≥15                               AHI\<15 = 99          73                                               50

10.1371/journal.pone.0143697.t002

###### Demographic data of patients using STOP-Bang questionnaire.

![](pone.0143697.t002){#pone.0143697.t002g}

  Study ID                                           No. of patients   Age (Year)   Gender (%) Male/Female   BMI (Kg/m^2^)   Neck Cir (cm)   STOP-Bang Score   AHI (mean)   Minimum SPO2 (%)
  -------------------------------------------------- ----------------- ------------ ------------------------ --------------- --------------- ----------------- ------------ ------------------
  **Sleep Clinic population**                                                                                                                                               
    ^\[^ [@pone.0143697.ref020] ^\]^Ong^2010^        314               46.8±15      70/30                    27.9±6          39.8±4          3.8±2             26.2±27      82±13
    ^\[^ [@pone.0143697.ref021] ^\]^Farney^2011^     1426              49.7±15      57/43                    33.8±8          40.7±5          4.3±2             32.9±30      NA
    ^\[^ [@pone.0143697.ref022] ^\]^El-Sayed^2012^   234               50.3±11      85/15                    37.7±1          42.4±4          5.6±2             45.6±33      NA
    ^\[^ [@pone.0143697.ref023] ^\]^Yu^2012^         114               40.5±02      89/11                    28.2±2          39.5±3          3.8±1             NA           NA
    ^\[^ [@pone.0143697.ref024] ^\]^Boynton^2013^    219               46.3±14      44/56                    33.4±9          39.9±5          3.9±2             NA           NA
    ^\[^ [@pone.0143697.ref025] ^\]^Pereire^2013^    128               50.0±12      65/35                    31.0±7          41.0±4          NA                33.1±28      NA
    ^\[^ [@pone.0143697.ref026] ^\]^Vana^2013^       47                46.4±13      34/66                    36.3±9          38.1±5          5.0±2             08.9±24      NA
    ^\[^ [@pone.0143697.ref027] ^\]^Cowan^2014^      129               49.0±11      63/37                    32.0±6          NA              NA                NA           NA
    ^\[^ [@pone.0143697.ref028] ^\]^Ha ^2014^        139               45.0±11      82/18                    26.0±4          NA              NA                25.0±24      80±9
    ^\[^ [@pone.0143697.ref029] ^\]^Luo ^2014^       212               44.8±12      88/12                    28.1±4          41.1±3          4.4±1             43.7±02      74±13
    ^\[^ [@pone.0143697.ref030] ^\]^Reis^2015^       215               53.6±13      71/29                    29.0±5          40.4±44         4.4±2             16.7±20      NA
  **Surgical population**                                                                                                                                                   
    ^\[^ [@pone.0143697.ref017] ^\]^Chung^2008^      177               56.0±13      60/40                    30.0±6          39±6            NA                20.0±06      82±11
    ^\[^ [@pone.0143697.ref018] ^\]^Chung^2012^      746               60.0±11      49/51                    30.0±6          NA              NA                NA           NA
    ^\[^ [@pone.0143697.ref019] ^\]^Nunes^2014^      81                56.0±07      70/30                    29.5±5          NA              NA                NA           NA
  **General population**                                                                                                                                                    
    ^\[^ [@pone.0143697.ref031] ^\]^Silva^2011^      4770              62.4±10      51/49                    NA              NA              3.4±1             NA           NA
  **Highway bus drivers**                                                                                                                                                   
    ^\[^ [@pone.0143697.ref032] ^\]^Firat^2012^      85                NA           NA                       29.1±4          41.1±3          NA                21.1±17      NA
  **Renal failure patients**                                                                                                                                                
    ^\[^ [@pone.0143697.ref033] ^\]^Nicholl^2013^    172               63.0±13      63/37                    29.3±7          41±5            4±1.5             RDI = 13.5   NA

Methodological quality of the included studies {#sec015}
----------------------------------------------

All included studies used PSG as a valid reference test to verify the accuracy of the STOP-Bang questionnaire, confirming internal validity ([S2 Appendix](#pone.0143697.s002){ref-type="supplementary-material"}). For validation purposes, 12 studies used laboratory PSG\[[@pone.0143697.ref017],[@pone.0143697.ref019]--[@pone.0143697.ref026],[@pone.0143697.ref028],[@pone.0143697.ref029],[@pone.0143697.ref032]\], while three used portable PSG (level 3 PSG\[[@pone.0143697.ref027],[@pone.0143697.ref033]\] or level 2 PSG\[[@pone.0143697.ref031]\] and two studies used laboratory or portable level 2/3 PSG\[[@pone.0143697.ref018],[@pone.0143697.ref030]\]. All included studies had specific information to clearly evaluate the risk of bias during the validation process of the STOP-Bang questionnaire. The following aspects were available in the chosen publications: 1) Blinded interpretation of the PSG and STOP-Bang questionnaire (i.e. those who scored the PSG were unaware of the results of the STOP-Bang questionnaire and vice versa); and 2) Interpretation of the PSG results was performed independent of the patient's clinical history. In terms of the external validity, all studies adequately met the appraisal items with one minor exception\[[@pone.0143697.ref032]\] ([S3 Appendix](#pone.0143697.s003){ref-type="supplementary-material"}). All studies clearly mentioned the inclusion and exclusion criteria.

The following abbreviations were used to evaluate the internal and external validity of the studies. F: Full meeting criteria; P: partially meeting criteria; U: Unsure if meeting criteria in subgroups; N: not meeting criteria in subgroup; N/A: not applicable.

### Predictive parameters of STOP-Bang questionnaire in the sleep clinic population {#sec016}

The pooled predictive parameters of a STOP-Bang score ≥3 as the cut-off in the sleep clinic population are presented in [Table 3](#pone.0143697.t003){ref-type="table"} and Figs [3](#pone.0143697.g003){ref-type="fig"} & [4](#pone.0143697.g004){ref-type="fig"}. The prevalence of any OSA (AHI ≥5), moderate-to-severe OSA (AHI ≥15) and severe OSA (AHI ≥30) was 85%, 64% and 42% respectively. The pooled sensitivity of the STOP-Bang questionnaire to predict any OSA, moderate-to-severe and severe OSA was 90% (95%CI: 88%-91%; I^2^ = 82.9%), 94% (95%CI: 92%-95%; I^2^ = 64.8%) and 96% (95%CI: 95%-97%; I^2^ = 57.8%) respectively. The corresponding pooled NPVs were 46% (95% CI: 41%-50%), 75% (95% CI: 71%-79%) and 90% (95% CI: 87%-93%) respectively. The pooled specificity was relatively low (49%, 34% and 25% respectively). The PPV was 91%, 72% and 48% for any OSA, moderate-to-severe and severe OSA respectively. The corresponding pooled DOR were 8.3, 7.2 and 7.2 respectively. The area under the ROC curve was consistently \>0.72 for all OSA severities.

![Forest plot for pooled sensitivity and specificity for various OSA severities in Sleep Clinic populations.\
TP---True Positive, FP---False Positive, FN---False Negative, TN---True Negative, CI---confidence Interval.](pone.0143697.g003){#pone.0143697.g003}

![Forest plot for pooled Diagnostic odds ratio for various OSA severities in Sleep Clinic populations.\
OR---Odd Ratio, CI---Confidence Interval.](pone.0143697.g004){#pone.0143697.g004}

10.1371/journal.pone.0143697.t003

###### Pooled Predictive parameters of STOP-Bang ≥3 as cut-off.

![](pone.0143697.t003){#pone.0143697.t003g}

  Predictive parameters         Mild OSA AHI ≥5          Moderate-to-Severe OSA AHI ≥15   Severe OSA AHI ≥30
  ----------------------------- ------------------------ -------------------------------- -----------------------
  **Sleep clinic population**                                                             
                                (11 studies, n = 3175)   (11 studies, n = 3175)           (9 studies, n = 2996)
   Prevalence                   85.0 (83.0--86.0)        64.0 (62.0--65.0)                42.0 (40.0--43.0)
   Sensitivity                  90.0 (88.0--91.0)        94.0 (93.0--95.0)                96.0 (95.0--97.0)
   Specificity                  49.0 (45.0--54.0)        34.0 (31.0--36.0)                25.0 (23.0--27.0)
   Positive predictive value    91.0 (90.0--92.0)        72.0 (70.0--74.0)                48.0 (46.0--50.0)
   Negative predictive value    46.0 (41.0--50.0)        75.0 (71.0--79.0)                90.0 (87.0--93.0)
   Diagnostic odds ratio        8.3 (6.1--9.7)           7.2 (5.7--9.0)                   7.2 (5.1--10.2)
   SROC                         0.74                     0.78                             0.72
  **Surgical population**                                                                 
                                (2 studies, n = 923)     (3 studies, n = 1002)            (2 studies, n = 923)
   Prevalence                   68.0 (65.0--71.0)        39.0 (36.0--42.0)                19.0 (21.0--27.0)
   Sensitivity                  84.0 (81.0--87.0)        91.0 (87.0--93.0)                96.0 (92.0--98.0)
   Specificity                  43.0 (38.0--49.0)        32.0 (28.0--36.0)                29.0 (26.0--33.0)
   Positive predictive value    76.0 (73.0--79.0)        46.0 (42.7--50.0)                23.0 (21.0--27.0)
   Negative predictive value    55.0 (48.8--62.0)        84.0 (79.0--88.0)                97.0 (94.0--99.0)
   Diagnostic odds ratio        4.46 (2.5--7.96)         4.08 (1.58--10.53)               11.31(2.07--61.7)
   SROC                         0.64                     0.68                             0.63

### Predictive parameters of the STOP-Bang questionnaire in the surgical population {#sec017}

The pooled predictive parameters of a STOP-Bang score ≥3 as the cut-off in surgical patients are presented in [Table 3](#pone.0143697.t003){ref-type="table"} and Figs [5](#pone.0143697.g005){ref-type="fig"} & [6](#pone.0143697.g006){ref-type="fig"}. The prevalence of OSA for any OSA, moderate-to-severe and severe OSA was 68.4%, 39.2% and 18.7% respectively. The corresponding sensitivities were 84% (95%CI: 81%-87%; I^2^ = 0%), 91% (95%CI: 87%-93%; I^2^ = 0%) and 96% (95%CI: 92%-98%; I^2^ = 72.7%) respectively; while the NPVs were 56% (95%CI: 49%-62%), 84% (95% CI: 79%-89%) and 97% (95%CI: 94%-99%) respectively. The specificity for any OSA, moderate-to-severe and severe OSA was 43%, 32% and 29% respectively, and the PPVs were 76%, 46% and 24% respectively. The corresponding DOR were 4.5, 4.0 and 11.3. The area under the ROC was consistently \>0.6 for all OSA severities.

![Forest plot for pooled sensitivity and specificity for various OSA severities in surgical populations.\
TP---True Positive, FP---False Positive, FN---False Negative, TN---True Negative, CI---confidence Interval.](pone.0143697.g005){#pone.0143697.g005}

![Forest plot for pooled Diagnostic Odds Ratio for various OSA severities in Surgical populations.\
OR---Odd Ratio, CI---Confidence Interval.](pone.0143697.g006){#pone.0143697.g006}

### Predictive parameters of the STOP-Bang questionnaire in the general population {#sec018}

Silva et al.\[[@pone.0143697.ref031]\] evaluated the STOP-Bang questionnaire in 4770 participants in the Sleep Heart Health Study. The prevalence of moderate-to-severe OSA (RDI ≥15) and severe OSA (RDI ≥30) in this population was 12.7% and 7.2% respectively. The sensitivity of STOP-Bang score ≥3 as cut-off was 88% to detect moderate-to-severe OSA (RDI ≥15) and 93% to detect severe OSA (AHI ≥30). NPV was 95% and 98% respectively. The specificity remained at 30% and PPV was 16% and 9% respectively.

### Predictive parameters of the STOP-Bang questionnaire in highway bus drivers {#sec019}

The STOP-Bang questionnaire was evaluated to detect moderate-to-severe OSA in highway bus drivers by Firat et al.\[[@pone.0143697.ref032]\] The prevalence of moderate-to-severe OSA among the highway bus drivers was 54%. The sensitivity and specificity of a STOP-Bang score ≥3 as the cut-off to detect moderate-to-severe OSA were 87% and 49% respectively, whereas the positive and negative predictive values were 66% and 76% respectively. The DOR was 6.3 and area under the ROC was 0.68.

### Predictive parameters of the STOP-Bang questionnaire in renal failure patients {#sec020}

In renal failure patients, the prevalence of moderate-to-severe OSA (RDI ≥15) and severe OSA (RDI ≥30) was 42% and 29% respectively.\[[@pone.0143697.ref033]\] The sensitivities for a STOP-Bang score ≥ 3 as the cut-off to detect moderate-to-severe OSA (RDI ≥15) and severe OSA (RDI ≥30) were 93.1% and 98% respectively. The corresponding negative predictive values were 86% and 97%. The specificity was 30% and 27%. The PPV was 49% and 35% respectively.\[[@pone.0143697.ref033]\]

### Predictive performance of various STOP-Bang scores {#sec021}

The predictive parameters of the various STOP-Bang score cut-offs were analyzed in six studies (n = 2807)\[[@pone.0143697.ref018],[@pone.0143697.ref019],[@pone.0143697.ref021],[@pone.0143697.ref027],[@pone.0143697.ref029],[@pone.0143697.ref030]\]. Data from four studies (n = 1980)\[[@pone.0143697.ref021],[@pone.0143697.ref027],[@pone.0143697.ref029],[@pone.0143697.ref030]\] from the sleep clinic population, and two (n = 827)\[[@pone.0143697.ref018],[@pone.0143697.ref019]\] from the surgical population were pooled separately ([Table 4](#pone.0143697.t004){ref-type="table"} & [Fig 2](#pone.0143697.g002){ref-type="fig"}). In the sleep clinic population, as the STOP-Bang score cut-off increased from 3 to 8, the specificity increased from 52% to 100%, and the PPV increased continuously from 93% to 100% for any OSA (AHI ≥5). Similarly, for moderate-to-severe OSA (AHI ≥15) the specificity increased from 32% to 100%, and the PPV increased from 73% to 95%. For severe OSA (AHI ≥30) the specificity increased from 23% to 100% and PPV increased from 48% to 86% ([Table 4](#pone.0143697.t004){ref-type="table"}).

10.1371/journal.pone.0143697.t004

###### Predictive parameters of the various STOP-Bang score cut-offs for the different AHI levels in sleep clinic and surgical population.

![](pone.0143697.t004){#pone.0143697.t004g}

  Sleep Clinic population              Surgical population                                                             
  ------------------------------------ ------------------------------------ ----- ----- ----- -------- ----- ---- ---- -----
  **All OSA (AHI ≥5)**                 **All OSA (AHI ≥5)**                                                            
  ≥1                                   100                                  2     89    100   ≥1       99    3    69   50
  ≥2                                   98                                   20    90    58    ≥2       96    18   72   66
  ≥3                                   91                                   52    93    44    ≥3       84    40   75   54
  ≥4                                   76                                   71    95    30    ≥4       60    61   77   41
  ≥5                                   54                                   84    96    20    ≥5       36    80   79   37
  ≥6                                   30                                   93    97    16    ≥6       18    92   82   34
  ≥7                                   12                                   98    97    14    ≥7 & 8   4     98   82   32
  = 8                                  2                                    100   100   13                             
  **Moderate/ Severe OSA (AHI ≥15)**   **Moderate/ Severe OSA (AHI ≥15)**                                              
  ≥1                                   100                                  1     67    100   ≥1       99    7    40   94
  ≥2                                   99                                   10    68    79    ≥2       99    1    38   60
  ≥3                                   94                                   32    73    74    ≥3       90    11   39   61
  ≥4                                   81                                   51    76    58    ≥4       70    32   40   62
  ≥5                                   60                                   72    80    48    ≥5       45    56   40   61
  ≥6                                   35                                   89    86    42    ≥6       23    78   40   61
  ≥7                                   14                                   96    88    37    ≥7 & 8   4     95   37   61
  = 8                                  3                                    100   95    35                             
  **Severe OSA (AHI ≥30)**             **Severe OSA (AHI ≥30)**                                                        
  ≥1                                   100                                  1     42    100   ≥1       100   2    18   100
  ≥2                                   99                                   7     43    89    ≥2       100   10   20   100
  ≥3                                   96                                   23    47    88    ≥3       95    28   22   96
  ≥4                                   85                                   43    52    79    ≥4       78    52   26   92
  ≥5                                   66                                   66    58    72    ≥5       56    74   32   88
  ≥6                                   42                                   85    67    67    ≥6       28    88   35   85
  ≥7                                   19                                   96    76    60    ≥7 & 8   6     97   33   83
  = 8                                  4                                    100   86    58                             

In the surgical population, as the STOP-Bang score cut-off increased from 3 to ≥7, the specificity increased from 40% to 98% and the PPV increased from 75% to 82% for any OSA (AHI ≥5). Similarly, for moderate-to-severe OSA (AHI ≥15) the specificity increased from 11% to 95%, but the PPV decreased from 39% to 37%. For severe OSA (AHI ≥30) the specificity increased from 28% to 97% and PPV increased from 22% to 33% ([Table 4](#pone.0143697.t004){ref-type="table"}).

### Association between STOP-Bang scores and predictive probability {#sec022}

A meta-analysis was carried out in five studies (n = 2792),\[[@pone.0143697.ref018],[@pone.0143697.ref021],[@pone.0143697.ref029],[@pone.0143697.ref030],[@pone.0143697.ref051]\] three studies in sleep clinic patients (n = 1852)\[[@pone.0143697.ref021],[@pone.0143697.ref029],[@pone.0143697.ref030]\] and two studies in surgical patients, (n = 957)\[[@pone.0143697.ref018],[@pone.0143697.ref051]\]. The relationship between the predictive probabilities of moderate-to-severe or severe OSA and STOP-Bang scores is illustrated in [Fig 7](#pone.0143697.g007){ref-type="fig"}. In both sleep clinic (Panel A; n = 1852) and surgical patients (Panel B; n = 957), the probability of moderate-to-severe OSA, or severe OSA increased as the STOP-Bang score increased from 3 to 7/ 8. With higher scores, there is a more profound increase in the probability of severe OSA compared to moderate OSA.

![The relation between the various STOP-Bang scores and OSA probability.\
OSA---obstructive sleep apnea, AHI---apnea-hypopnea index, SBQ---STOP-Bang Questionnaire.](pone.0143697.g007){#pone.0143697.g007}

Discussion {#sec023}
==========

This review shows that the STOP-Bang questionnaire with a score ≥3 as the cut-off consistently demonstrates a high sensitivity to detect OSA in different patient populations; 94%(92--95) to detect moderate-to-severe OSA in sleep clinic patients and 91%(87--93) in surgical patients. The specificity at the same cut-off is modest, ranging from 34% in Sleep Clinic population to 32% in surgical population. As the STOP-Bang score increases, the probability of moderate and severe OSA increases. When the STOP-Bang score was 7 or 8, the probability of severe OSA was 75% in the sleep clinic population and 65% in the surgical population.

Given the relatively high prevalence of undiagnosed and untreated OSA\[[@pone.0143697.ref001],[@pone.0143697.ref006],[@pone.0143697.ref007]\] and its associated cardiovascular, respiratory, and neurocognitive morbidities\[[@pone.0143697.ref052]--[@pone.0143697.ref057]\], a simple and effective OSA screening tool is essential. This approach is important to perioperative care team, as often there is insufficient time to complete a preoperative assessment of OSA\[[@pone.0143697.ref058]\] with the standard diagnostic approach. The STOP-Bang questionnaire can fulfill this need given that it is a short, practical and straightforward test. The questionnaire can be completed within 1--2 minutes with very high response rates of 90--100%.\[[@pone.0143697.ref017]\]

Utilization of the STOP-Bang questionnaire in the sleep clinic population {#sec024}
-------------------------------------------------------------------------

Since patients are referred to the sleep clinic for a suspicion of sleep related disorders, the prevalence of OSA is high in this population. The high sensitivity and NPV with a STOP-Bang score ≥3 as the cut-off can help sleep clinicians exclude patients with very little chance of moderate-to-severe OSA. On the other hand, a patient with a high score (≥5) on the STOP-Bang questionnaire has a high probability of severe OSA. These patients warrant expedited diagnosis and treatment. With the STOP-Bang questionnaire, sleep clinicians can prioritize their patients and efficiently allocate their limited resources.

Utilization of the STOP-Bang questionnaire in the surgical population {#sec025}
---------------------------------------------------------------------

OSA is prevalent in surgical populations and is considered to be an independent risk factor for perioperative complications in non-cardiac surgeries.\[[@pone.0143697.ref052]--[@pone.0143697.ref057]\] Further, OSA is associated with the occurrence of major adverse cardiovascular and cerebrovascular events, repeated revascularization, angina, and atrial fibrillation following coronary artery bypass grafting (CABG).\[[@pone.0143697.ref059]\] Mutter et al. have shown that surgical patients with a diagnosis of OSA and continuous positive airway pressure (CPAP) prescription had lower rates of cardiovascular complications.\[[@pone.0143697.ref060]\] Further, patients with OSA who are not treated with CPAP preoperatively are at increased risks for cardiopulmonary complications after general and vascular surgery.\[[@pone.0143697.ref061]\] Therefore, it is important to identify patients at high-risk of having moderate-to-severe OSA preoperatively. However, the short time interval between the preoperative clinic visit and scheduled surgery date, lack of willingness from patients to undergo preoperative PSG and potentially long wait times for a sleep clinic appointment may hinder diagnosing OSA prior to surgery. By incorporating the STOP-Bang questionnaire into preoperative clinic practice, surgical patients can be risk stratified for OSA severity using the score. A STOP-Bang score of 0--2 has a high negative predictive value for assessing the likelihood of moderate or severe OSA, which can be used to mitigate the need for PSG. Patients with a high score on the STOP-Bang questionnaire (≥5) have a high probability of having moderate-to-severe OSA. Depending on the co-morbidities and type of surgery, they may need referral to a sleep clinic for further investigation before surgery or be treated as an OSA patient perioperatively. Being able to predict moderate-to-severe or severe OSA in the perioperative setting is clinically relevant so that clinicians can take the appropriate steps in mitigating the risk of perioperative complications associated with OSA (e.g. changes in anesthetic care, careful titration of opioids, CPAP administration and postoperative monitoring).

In a retrospective study, Prockzco et al.\[[@pone.0143697.ref048]\] compared the outcomes of patients undergoing bariatric surgery who had undergone preoperative PSG and were on CPAP therapy to those considered high risk for OSA based on STOP-Bang score ≥3 without preoperative PSG. Patients with a STOP-Bang score ≥3 had higher postoperative complications and an increased length of stay (LOS) compared to patients with OSA using CPAP therapy perioperatively and compared to patients with a STOP-Bang score 0--2. This study was in line with others who found that patients with a STOP-Bang score ≥3 versus 0--2 had higher postoperative complications and longer LOS.\[[@pone.0143697.ref036]\]\[[@pone.0143697.ref042]\] In a preoperative setting, a high STOP-Bang score may help in risk stratification and obviate the need for a PSG \[[@pone.0143697.ref062],[@pone.0143697.ref063]\]. Moreover, perioperative CPAP therapy may reduce hospital LOS.\[[@pone.0143697.ref064]\] Therefore, identifying and treating patients at high risk for moderate or severe OSA may help to potentially avoid perioperative complication. Further research is needed in this area.

The variation in the predictive parameters among the different populations may be due to the difference in sample sizes, age and gender discrepancies of the recruited patients, differences in associated co-morbidities, or cultural / racial differences. In a study by Kunisaki et al\[[@pone.0143697.ref050]\], a STOP-Bang score ≥3 showed a high sensitivity of 99%, but a low specificity of 5%, which may be due to the predominantly older male population. The specific combination of predictive factors in the STOP-Bang questionnaire may improve its specificity. For patients with a STOP ≥2, male gender, a BMI \>35 kg/m^2^ and a neck circumference \>40 cm were more predictive of OSA than age \[[@pone.0143697.ref065]\]. The specificity of the STOP-Bang questionnaire may be improved by the addition of serum bicarbonate levels.\[[@pone.0143697.ref066]\] Most of the studies in our meta-analysis were from sleep clinic population, where the prevalence of OSA is higher. Further studies are required in a variety of medical, surgical, and general populations.

This systematic review and meta-analysis has some limitations. One of the factors contributing to the moderate to high heterogeneity is the variability of the target populations among the different studies. In an effort to unify the subject populations, all studies were divided into major groups: sleep clinic, surgical and general populations. The other reason for the heterogeneity may be variation in the prevalence of OSA in the different populations. Also, there was a paucity of validation studies in surgical patients. Nonetheless, we used the random effects method, which is more suitable when heterogeneity exists. The other limitation is that a non-English study was excluded even though it showed high sensitivity for the STOP-Bang questionnaire.\[[@pone.0143697.ref040]\] There is significant correlation between sensitivity and specificity with clinical screening tools, and our statistical approach does not account for overestimation of overall diagnostic test accuracy related to interpretation of each measure individually. More advanced methods utilizing bivariate or Bayesian frameworks may be necessary to address this limitation. Although DOR provides a combined measure across both sensitivity and specificity, it may significantly underestimate the confidence intervals. Despite these limitations, our systematic review and meta-analysis provides the interpretation of the available literature on the STOP-Bang questionnaire as a screening tool in OSA patients.

In summary, the STOP-Bang questionnaire has been validated to be an excellent screening tool for OSA in sleep clinic and surgical population. The probability of moderate and severe OSA steadily increases with higher STOP-Bang scores. The high negative predictive value of the STOP-Bang questionnaire may indicate that patients are unlikely to have moderate-to-severe OSA. These characteristics make the STOP-Bang questionnaire a useful clinical tool to identify patients at high risk of OSA and can facilitate the diagnosis and treatment of unrecognized OSA.
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AHI

:   Apnea/Hypopnea Index

AUC

:   Area under the curve

BMI

:   Body mass index

CI

:   Confidence Interval

CPAP

:   Continuous Positive Airway Pressure

CVS

:   Cardiovascular system

DM

:   Diabetes Mellitus

DOR

:   Diagnostic Odds Ratio

EDS

:   Excessive daytime sleepiness

EGD

:   Esophagoscopy

FN

:   False Negative

FP

:   False Positive

Lab

:   Laboratory

LOS

:   Length of Hospital stay

n

:   number of patient

NA

:   Not available

Neck cir

:   Neck circumference

NPV

:   Negative Predictive value

NS

:   Not Significant

OR

:   Odds Ratio

OSA

:   Obstructive Sleep Apnea

Postop Cx

:   Postoperative Complication

PPV

:   Positive Predictive Value

PRISMA

:   Preferred Reporting Items for Systematic Reviews and Meta-analysis

PSG

:   Polysomnogram

RDI

:   Respiratory Disturbance Index

ROC

:   Receiver Operating Characteristic

SB

:   STOP-Bang questionnaire

SPO~2~

:   Hemoglobin oxygen saturation

SROC

:   Summary of receiver operating characteristic curve

TN

:   True Negative

TP

:   True Positive
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